Healthcare - Biotechnology - NASDAQ - US
$ 1.17
-7.14 %
$ 6.9 M
Market Cap
-0.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
96.94%
EBIT
Estimate
--25.06%
Net Income
Estimate
20.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Plus Therapeutics, Inc.
PSTV has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PSTV
EBIT FORECAST
EBIT Forecast Chart PSTV
NET INCOME FORECAST
Net Income Chart PSTV